Actavis, Inc. News Headlines

Get ACT Alerts
*Delayed - data as of Dec. 22, 2014 10:31 ET  -  Find a broker to begin trading ACT now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    ACT Real Time
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Filtered By
Ordered By
It's Not the Zombie Apocalypse, but Killer Superbugs Could Be on the Way
12/14/2014 7:44:04 AM - Motley Fool

What Investors Can Learn From The Portfolios Of Fund Managers
12/14/2014 5:47:00 AM - Seeking Alpha

Chilton opens new position in Wynn Resorts
12/12/2014 4:00:00 PM - Market Realist

Actavis Likely to Continue Selling Namenda IR Tablets - Analyst Blog
12/12/2014 3:20:00 PM -

Chilton starts new position in Medtronic
12/12/2014 12:00:00 PM - Market Realist

Chilton initiates new position in Actavis
12/12/2014 8:00:00 AM - Market Realist

Actavis Ordered By Court To Keep Selling Immediate-release Alzheimer''s Drug
12/11/2014 11:27:00 PM - RTT News

Chilton opens new position in Wynn Resorts
12/11/2014 8:22:00 PM - Market Realist

Highlights of Chilton Investment Company’s 3Q14 13F
12/11/2014 8:12:00 PM - Market Realist

bluebird bio (BLUE) Soars on Data from LentiGlobin Study - Analyst Blog
12/11/2014 4:45:00 PM -

Mylan Among First to Launch Generic Celebrex - Analyst Blog
12/11/2014 4:22:00 PM -

Drivers Of The Rally: Megamergers And Monetary Stimuli
12/10/2014 5:33:00 PM - Market Realist

Ironwood Pharmaceuticals Advances IW-9179 to Phase IIa - Analyst Blog
12/10/2014 3:30:00 PM -

Actavis Unveils Generic Version Of Celebrex - Quick Facts
12/10/2014 9:35:00 AM - RTT News

Google, Microsoft Dominate Mutual Funds, Apple Still Most Popular In Hedge Funds: Citigroup
12/8/2014 8:13:00 PM - Seeking Alpha

Actavis' Antibiotic Backed for FDA Approval, Response in Q1 - Analyst Blog
12/8/2014 6:30:00 PM -

Bristol-Myers Posts Positive Opdivo Hodgkin Lymphoma Data - Analyst Blog
12/8/2014 5:10:00 PM -

Is It Time to Buy This Growth Stock?
12/8/2014 9:43:02 AM - Motley Fool

Why 2014 Is the Biggest Year for Deals Since the Financial Crisis
12/8/2014 6:10:00 AM - TheStreet

The 3 Most Memorable Moments in Healthcare This Year
12/7/2014 3:02:02 PM - Motley Fool

Actavis: FDA Committee Recommends Approval Of Antibiotic Ceftazidime-avibactam
12/5/2014 4:51:00 PM - RTT News

Consumer Health Spending a Welcome Wrinkle for Allergan-Actavis Deal
12/4/2014 10:24:02 AM - Motley Fool

Oncolytics Files for Orphan Drug Designation for Reolysin - Analyst Blog
12/3/2014 4:30:00 PM -

Pain Therapeutics' Remoxy Would Be A Good Fit For Any Of These Experienced Companies
12/3/2014 3:41:00 PM - Seeking Alpha

5 Stocks Hedge Funds Love: Alibaba, MIcrosoft and More
12/3/2014 10:35:00 AM - TheStreet